China Universal Asset Management Co., Ltd. Vera Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 10,117 shares of VERA stock, worth $360,468. This represents 0.06% of its overall portfolio holdings.
Number of Shares
10,117
Previous 10,117
-0.0%
Holding current value
$360,468
Previous $436,000
-0.0%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$188 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$118 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$113 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$105 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$99.5 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $964M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...